Tag: Adial Pharmaceuticals


Adial Pharmaceuticals Inc (NASDAQ: ADIL) Affords Governing and Progress Apprise

Adial Pharmaceuticals Inc (NASDAQ: ADIL) today announced that it had obtained correspondence related to its application for Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its medicine candidate, AD04. The candidate will be used to cure Alcohol Use Disorder (AUD) in pediatric patients and adult patients […]


Adial Pharmaceuticals Inc. (NASDAQ: ADIL) Jumps 21% Following Grant of Patent Notice For Genetic Diagnostic Panel

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) jumped 21.19%  after the company announced plans to foray into the genetic testing market following the grant of a Notice of Allowance from the US patent and Trademark Office (USPTO).  Adial receives a patent related to AD04 The patent notice is related to using the […]